drugset / Trial / NCT05421338
A Study in Healthy Men to Test How BI 456906 is Processed in the Body
NaSingle-groupOpen-labelTreatment
Summary
This trial is intended to examine the basic pharmacokinetics of BI 456906 and total \[14C\]-radioactivity, including mass balance, excretion pathways and metabolism following a single subcutaneous (SC) dose of BI 456906 (C-14) in (otherwise) healthy male volunteers with normal body weight, overweight or obesity.
Timeline
- Start
- 2022-07-04
- Primary completion
- 2022-11-17
- Completion
- 2022-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Survodutide | Protein / enzyme biologic | — | Subcutaneous |
Indications
No indication recorded.